Content Status

Type

Linked Node

H5Content
Content

The following points should be covered in follow-up monitoring of Drug-resistant TB (DR-TB) patients:

 

  • Monitor DR-TB treatment progress and disease response.
  • Monitor bacteriological and radiological improvements in DR-TB treatment.
  • Identify derangements in bio-chemical results and on Electrocardiogram (ECG) which are indicative of systemic disorders that could result in drug-induced adverse events, or comorbidities that may require timely interventions to address and improve the probability of treatment success, survival and quality of life.
  • Follow-up monitoring to be done periodically based on the type of TB/ severity of disease/ type of regimen used, etc.

 

Components of Follow-up Monitoring 

 

  1. Clinical monitoring
  2. Follow-up evaluations

 

Resources

 

 

Kindly provide your valuable feedback on the page to the link provided HERE

Content Creator

Reviewer